Kimia Biosciences (BOM:530313) EV-to-Revenue : (As of Jun. 05, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kimia Biosciences's enterprise value is ₹2,302.71 Mil. Kimia Biosciences does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Kimia Biosciences's EV-to-Revenue at this moment.

The historical rank and industry rank for Kimia Biosciences's EV-to-Revenue or its related term are showing as below:

BOM:530313's EV-to-Revenue is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.28
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), Kimia Biosciences's stock price is ₹48.67. Kimia Biosciences does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Kimia Biosciences's PS Ratio at this moment.

Kimia Biosciences EV-to-Revenue Historical Data

The historical data trend for Kimia Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences EV-to-Revenue Chart

Kimia Biosciences Annual Data

Trend

EV-to-Revenue

Kimia Biosciences Semi-Annual Data

EV-to-Revenue

Competitive Comparison of Kimia Biosciences's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's EV-to-Revenue falls into.

Kimia Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kimia Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2302.711	/
	=

Kimia Biosciences (BOM:530313) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kimia Biosciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	48.67	/
	=

Kimia Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines